Navigation Links
Linhardt to discuss drug safety and the impacts of globalization on pharmaceutical manufacturing
Date:2/1/2011

Troy, N.Y. Robert J. Linhardt will discuss drug safety in an increasingly global economy during the 2011 AAAS Annual Meeting in Washington, D.C.

Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer, will present on how to maintain a safe drug supply on Saturday, Feb. 19, from 8 to 9 a.m. in room 147B of the Washington Convention Center, during the symposium titled "Medicine Safety in a World of Science Without Borders."

Linhardt, who was named in 2009 as one the Scientific American 10 for his lifesaving work, is among the world's foremost experts on the commonly used blood thinner heparin. His research has helped make the currently available heparin safer for patients and is leading the effort to create a safer, fully synthetic alternative to the current heparin, which is harvested from the intestines of mostly foreign livestock. During the symposium, he will discuss this research and lessons that he learned when people around the world died after taking what were thought to be routine dosages of heparin.

Following the deaths of patients around the world from a dosage of heparin in early 2008, scientists scrambled to find the cause. In April 2008, Linhardt and a small team of scientists announced the source of the patient death and illness a complex carbohydrate named oversulfated chondroitin sulfate. It was a contaminant so structurally similar to heparin it was nearly undetectable to some of the most advanced technology available.

Linhardt and Jian Liu at the University of North Carolina discovered the "recipe" for synthetic heparin five years ago. Today, Linhardt and his team have prepared a purer, safer alternative creating the first fully synthetic heparin, and the largest amount ever created in the laboratory.

Linhardt will be joined in the discussion by fellow heparin experts Zachary Shriver of the Massachusetts Institute of Technology and Ali Al-Hakim of the U.S. Food and Drug Administration.


'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
Source:Eurekalert

Related medicine news :

1. mHealth Alliance Works in Partnership with GSMA to Expand Discussion of Mobile Health at 2010 Mobile World Congress
2. NAMI Encourages DSM-5 Discussion
3. WellPoint To Hold Conference Call and Webcast To Discuss 2010 Financial Outlook on March 17, 2010
4. The Future of Cosmetic Dermatology: Leading Dermatologist Dr. David Goldberg Discusses the Latest Facial Rejuvenation Techniques
5. David Anderson to discuss what model organisms can teach us about emotion
6. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
7. NAE, IOM members to discuss engineering innovations in health care at Feb. 25 meeting
8. AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on Inside Government Radio Show
9. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
10. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
11. Improvements needed in genomic test result discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology: